Skip to main content
Lime Chemicals Ltd. logo

Lime Chemicals Ltd. — Investor Relations & Filings

Ticker · 507759 ISIN · INE891G01011 BSE.NS Manufacturing
Open in API
Filings indexed 274 across all filing types
Latest filing 2026-03-10 Board/Management Inform…
Country IN India
Listing BSE.NS 507759

About Lime Chemicals Ltd.

https://www.limechem.com/

Lime Chemicals Ltd. specializes in the production of high-quality Calcium Carbonate, specifically focusing on Precipitated Calcium Carbonate (PCC) and Activated Calcium Carbonate. The company operates manufacturing facilities that utilize advanced carbonation processes to ensure high purity and specific particle size distributions. Its product portfolio serves a wide range of industrial applications, including the formulation of oral care products like toothpaste, pharmaceutical excipients, and fillers for the polymer, rubber, and paper sectors. The company provides various grades tailored to meet stringent technical specifications for opacity, brightness, and chemical stability. By maintaining a focus on research and development, the firm supports specialized requirements in the plastics and coatings industries, positioning itself as a key supplier of mineral-based functional additives.

Recent filings

Filing Released Lang Actions
Lime Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/03/2026 ,inter alia, to consider and approve 1. To Shift the Registered Office ....
Board/Management Information Classification · 95% confidence The document is a notice informing the stock exchange about an upcoming Board Meeting scheduled for 13th March 2026. The agenda includes shifting the registered office and appointing an additional independent director, subject to member approval. There is no financial data, report, or results disclosed here, only an announcement of a board meeting and its agenda. This fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board or senior management.
2026-03-10 English
Details regarding resignation of CFO and appointment of new CFO is attached herewith.
Regulatory Filings
2026-03-06 English
Submitting the reply to the clarification sought on price movement is attached herewith.
Regulatory Filings Classification · 95% confidence The document is a letter from Lime Chemicals Limited responding to a query from the stock exchange regarding unusual price movement of the company's shares. It references compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events. The letter states that there is no material information or event to disclose at this time. The document is short (1316 characters) and serves as a regulatory communication clarifying the absence of price sensitive information rather than a financial report or announcement of a report. It is not an annual report, earnings release, or any other detailed financial or management report. It fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements and compliance communications that do not fit other categories.
2026-03-05 English
Quarterly results for the quarter ended on 31st December 2025 is attached.
Regulatory Filings
2026-02-14 English
Outcome of Board Meeting is attached herewith.
Regulatory Filings
2026-02-14 English
Lime Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2026 ,inter alia, to consider and approve A meeting of the Board of Directors ....
Regulatory Filings Classification · 95% confidence The document is a short notice informing the stock exchange about an upcoming Board Meeting to approve un-audited financial results for the quarter ended December 31, 2025. It does not contain the financial results themselves, only an announcement of the meeting date and agenda. The document length is under 5,000 characters and it serves as a notification rather than a report. Therefore, it fits the category of a Regulatory Filing (RNS) as a general regulatory announcement rather than an Interim/Quarterly Report (IR) or Earnings Release (ER).
2026-02-03 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.